` ALECR (Eurofins-Cerep SA) vs DAX Index Comparison - Alpha Spread

ALECR
vs
DAX Index

Over the past 12 months, ALECR has underperformed DAX Index, delivering a return of 0% compared to the DAX Index's 31% growth.

Stocks Performance
ALECR vs DAX Index

Loading
ALECR
DAX Index
Add Stock
www.alphaspread.com

Performance Gap
ALECR vs DAX Index

Loading
ALECR
DAX Index
Difference
www.alphaspread.com

Performance By Year
ALECR vs DAX Index

Loading
ALECR
DAX Index
Add Stock

Competitors Performance
Eurofins-Cerep SA vs Peers

DAX Index
ALECR
0KHE
TMO
DHR
207940
Add Stock

Eurofins-Cerep SA
Glance View

Market Cap
111m EUR
Industry
Life Sciences Tools & Services

Eurofins-Cerep SA engages in providing preclinical drug research services. The company is headquartered in Celle-Levescault, Nouvelle-Aquitaine and currently employs 211 full-time employees. The company went IPO on 2010-03-19. The Company, using its BioPrint technology systems that analyzes pharmaceutical drugs on the market, those that have been withdrawn, and those that failed in the development stages, builds up predictive models of the potential of new drugs. These predictions are based on the drugs' chemical structure and their performance in vitro. The firm then offers solutions to the pharmaceutical and biotechnology sectors on reducing time and costs in the early stages of the drug development process. Clients can also gain access to some of the Company's technology by subscribing to BioPrint. In December 2013, it sold Cerep Inc, its American subsidiary, to Eurofins-Panlabs Inc, part of the Eurofins Scientific SE group.

ALECR Intrinsic Value
11 737.87 EUR
Overvaluation 47%
Intrinsic Value
Price
Back to Top